Healthcare

United Kingdom

The healthcare sector in the UK and internationally continues to experience a period of dynamic change underpinned by significant legal reforms and devolution to the four British nations. As an owner, operator or service provider in this sector, you are facing a highly regulated environment combined with increased public scrutiny. With increasing opportunities for the private provision of healthcare along with an ageing population, but with shrinking public healthcare budgets, operating within the healthcare sector presents both challenges and opportunities.

We act for many prominent industry players, advising on matters in all areas of health and social care including significant corporate, insolvency and banking matters, as well as regulation, insurance, procurement and competition issues. Our track record includes several sales and acquisitions valued at over GBP 100m and a number of PPP/PFI projects valued in excess of GBP 50m.

We have also built up a reputation for advising on innovative models of healthcare provision, such as managed services. Our expertise includes advising on collaborations with the NHS and with other organisations.

Long-standing clients include Nuffield Health, Sovereign Capital Partners, Spire Healthcare, IAC Investments LLP, John Laing, RBS Healthcare team, Lloyds Bank plc, Lloyds Development Capital, the National Fostering Agency, LGV Capital, Balfour Beatty plc, MML Capital, Bupa, Octopus Investments and Bridges Ventures.

Read more Read less
Highlights of our experience in Healthcare in the...
Lifesciences
Law-Now: Healthcare
Visit Law-Now for legal know-how and commentary

Feed

Show only
Warren Taylor
14 February 2017
Health Tech 2017: a case for greater connection
06/02/2016
CMS launches Global Product Liability team in Life...
15/12/2015
CMS Global Lifesciences Forum Report 2015
04/12/2015
The Antidote - Winter 2015
Sandra Rafferty
09/09/2014
The Antidote: Taking a look at corporate inversion...
03/06/2014
Wonder and Danger: Asian Legal Business - May 2014
01/05/2014
The Antidote - Spring 2014
Taking a look at "pharmerging" markets and the res...
Highlights of our experience in Healthcare in the...
Lifesciences